Search company, investor...

Predict your next investment

H & A Lux VCH Expert Biotech

Investments

1

About H & A Lux VCH Expert Biotech

Headquarters Location

Want to inform investors similar to H & A Lux VCH Expert Biotech about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

H & A Lux VCH Expert Biotech Investments

1 Investments

H & A Lux VCH Expert Biotech has made 1 investments. Their latest investment was in Alaunos Therapeutics as part of their PIPE on May 5, 2006.

CBI Logo

H & A Lux VCH Expert Biotech Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/5/2006

PIPE

Alaunos Therapeutics

$37M

Yes

Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management

Date

5/5/2006

Round

PIPE

Company

Alaunos Therapeutics

Amount

$37M

New?

Yes

Co-Investors

Abu Dhabi Investment Authority, Andrew Carter Capital, Broadlawn Capital Management, Bushido Capital Partners, Clarion Capital Partners, Cycad Group, Dorset Management Corporation, Downsview Capital, Emerging Technology Center, FCP OP MEDICAL BioHelth-Trends, H & A Lux VCH Expert Biotech, Hackney Group, Hauck & Aufhauser, Henderson Global Investors, Highbridge Capital Management, Hollis Capital Management, Iroquois Capital Group, Knott Partners, LBi International, Lewis Asset Management, Medical Strategy, Mehta Partners, Millennium Management, Mosaix Ventures, Panacea Asset Management, ProQuest Investments, Quantitative Bioequities Management, Riverside Contracting, Sterling Securities International, and Visium Asset Management

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.